These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21990244)

  • 21. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991).
    Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty MH; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 1993 Jan; 202(2):304-6. PubMed ID: 8428842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TP53 gene mutations in canine osteosarcoma.
    Kirpensteijn J; Kik M; Teske E; Rutteman GR
    Vet Surg; 2008 Jul; 37(5):454-60. PubMed ID: 18986312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of RA233 on metastasis in dogs with osteosarcomas.
    Hamilton HB; LaRue SM; Withrow SJ
    Am J Vet Res; 1987 Sep; 48(9):1380-2. PubMed ID: 3477971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal bone transport for treatment of primary bone tumors in dogs: technique description and outcome in 9 dogs.
    Ehrhart N
    Vet Surg; 2005; 34(1):24-34. PubMed ID: 15720593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limb-sparing treatment for osteosarcoma in dogs.
    LaRue SM; Withrow SJ; Powers BE; Wrigley RH; Gillette EL; Schwarz PD; Straw RC; Richter SL
    J Am Vet Med Assoc; 1989 Dec; 195(12):1734-44. PubMed ID: 2599960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of an artificial lymphatic system during carboplatin infusion to improve canine osteosarcoma blood flow and clinical response.
    DiResta GR; Aiken SW; Brown HK; Bergman PJ; Hohenhaus A; Ehrhart EJ; Baer K; Healey JH
    Ann Surg Oncol; 2007 Aug; 14(8):2411-21. PubMed ID: 17503157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orthogonal bone plate stabilization for limb-sparing surgery.
    Renwick A; Scurrell E
    Vet Comp Orthop Traumatol; 2013; 26(6):505-9. PubMed ID: 24081486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.
    Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I
    Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
    Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
    Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo.
    Goupil RC; Bushey JJ; Peters-Kennedy J; Wakshlag JJ
    Vet Pathol; 2012 Sep; 49(5):802-10. PubMed ID: 22287649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterisation of cancer stem cells from canine osteosarcoma.
    Wilson H; Huelsmeyer M; Chun R; Young KM; Friedrichs K; Argyle DJ
    Vet J; 2008 Jan; 175(1):69-75. PubMed ID: 17851099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
    Shoieb AM; Hahn KA; Barnhill MA
    In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM; Parker LM
    Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks?
    Rodriguez CO
    Adv Exp Med Biol; 2014; 804():237-56. PubMed ID: 24924178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Canine osteosarcoma as a model in comparative oncology].
    Parodi AL
    Sem Hop; 1982 Sep; 58(30-31):1731-5. PubMed ID: 6291155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and predictive biomarkers of canine osteosarcoma.
    Selvarajah GT; Kirpensteijn J
    Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
    Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
    J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limb salvage for primary malignant bone tumour.
    Dyce J; Houlton J; Dobson J; Morris J
    Vet Rec; 1992 Dec; 131(23):543-4. PubMed ID: 1475905
    [No Abstract]   [Full Text] [Related]  

  • 39. Osteosarcoma of the penile bone (os penis) in a dog.
    Peppler C; Weissert D; Kappe E; Klump S; Kramer M; Reinacher M; Neiger R
    Aust Vet J; 2009; 87(1):52-5. PubMed ID: 19178479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
    Mason NJ
    Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.